St John's Wort for Depression
- 24 January 2000
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 160 (2), 152-156
- https://doi.org/10.1001/archinte.160.2.152
Abstract
To address whether St John's wort is useful for the treatment of depression we attempted to retrieve all English-language articles with data on the efficacy, safety, and availability of St John's wort. Randomized, controlled, double-blind trials were selected and assessed for methodological quality using a standardized checklist, and data on pharmacology, cost, regulation, and safety were extracted. Eight studies were identified, found to be of generally good methodological quality, and determined to provide a modest amount of data to suggest that St John's wort is more effective than placebo in the treatment of mild to moderate depression. The absolute increased response rate with the use of St John's wort ranged from 23% to 55% higher than with placebo, but ranged from 6% to 18% lower compared with tricyclic antidepressants. More data are required to assess both its use in severe depression and its efficacy compared with other antidepressants. Rates of side effects were low. As a dietary supplement, St John's wort is currently largely unregulated, but the Food and Drug Administration is reviewing plans to tighten its regulatory oversight.Keywords
This publication has 15 references indexed in Scilit:
- Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre studyHuman Psychopharmacology: Clinical and Experimental, 1998
- Treatment of Seasonal Affective Disorder (SAD) with Hypericum ExtractPharmacopsychiatry, 1997
- Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an OverviewPharmacopsychiatry, 1997
- Effects of Long-Term Administration of Hypericum Extracts on the Affinity and Density of the Central Serotonergic 5-HT1 A and 5-HT2 A ReceptorsPharmacopsychiatry, 1997
- In VitroReceptor Binding and Enzyme Inhibition byHypericum perforatumExtractPharmacopsychiatry, 1997
- Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 OutpatientsJournal of Geriatric Psychiatry and Neurology, 1994
- Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed PatientsJournal of Geriatric Psychiatry and Neurology, 1994
- Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160Journal of Geriatric Psychiatry and Neurology, 1994
- Hypericum Treatment of Mild Depressions with Somatic SymptomsJournal of Geriatric Psychiatry and Neurology, 1994
- Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind StudyJournal of Geriatric Psychiatry and Neurology, 1994